Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › BET inhibitors as a treatment for myelofibrosis

BET inhibitors as a treatment for myelofibrosis

US Patent 12357621 · Granted Jul 15, 2025

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods for treating cancer and the use of biomarkers as a predictor of clinical2025
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2025
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2025
Methods of treating cancer by targeting cold tumors2025
Methods of treating cancer by targeting cold tumors2025
Substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors2025
Substituted benzimidazole derivatives as D-amino acid oxidase (DAAO) inhibitors2024
Methods of treating prostate cancer2024
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2023
Substituted 4-aminoisoindoline-1,3-dione compounds and second active agents for 2023
Use of known compounds as D-amino acid oxidase inhibitors2022
Methods for treating cancer and the use of biomarkers as a predictor of clinical2022